Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01683084 · ClinicalTrials.gov registry record · Phase 4
Study of the Effectiveness of Telmisartan in Slowing the Progression of Abdominal Aortic Aneurysms
A Phase 4 study, sponsored by Palo Alto Veterans Institute for Research.
- Completed
- Registry status
- Phase 4
- Development phase
- 22
- Enrollment target
NCT01683084 is a Phase 4 study that has completed, run by Palo Alto Veterans Institute for Research. The registered enrollment target is 22 participants.
The verdict
NCT01683084, a Phase 4 study, has completed, sponsored by Palo Alto Veterans Institute for Research.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 22 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if telmisartan is effective in slowing the progression of abdominal aortic aneurysms and reducing circulating concentrations of Abdominal Aortic Aneurysms (AAA) biomarkers.
Interventions
- DRUG Placebo
- DRUG Telmisartan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2012-09-19 |
| Est. Completion | 2018-11-10 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01683084
The ClinicalTrials.gov registry entry for NCT01683084 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Palo Alto Veterans Institute for Research, which has 35 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01683084 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01683084 about?
NCT01683084 is a clinical study titled "Study of the Effectiveness of Telmisartan in Slowing the Progression of Abdominal Aortic Aneurysms". The purpose of this study is to determine if telmisartan is effective in slowing the progression of abdominal aortic aneurysms and reducing circulating concentrations of Abdominal Aortic Aneurysms (AAA) biomarkers.
What is the current status of trial NCT01683084?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 22 participants. The study started on 2012-09-19. Estimated completion is 2018-11-10.
What interventions are being tested in trial NCT01683084?
The interventions under investigation include: Placebo (DRUG), Telmisartan (DRUG).
Who is sponsoring clinical trial NCT01683084?
This trial is sponsored by Palo Alto Veterans Institute for Research, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.